Acute myeloid leukemia—Major progress over four decades and glimpses into the future

Elihu H. Estey, Peter F. Thall, Sherry Pierce, Jorge Cortes, Miloslav Beran, Hagop Kantarjian, Michael J. Keating, Michael Andreeff, Emil Freireich, Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Blood. ,vol. 93, pp. 2478- 2484 ,(1999) , 10.1182/BLOOD.V93.8.2478.408K04_2478_2484

Mike Dennis, Nigel Russell, Robert K. Hills, Claire Hemmaway, Nicki Panoskaltsis, Mary-Frances McMullin, Lars Kjeldsen, Helen Dignum, Ian F. Thomas, Richard E. Clark, Don Milligan, Alan K. Burnett, Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia. Blood. ,vol. 125, pp. 2923- 2932 ,(2015) , 10.1182/BLOOD-2014-10-608117

Raynier Devillier, Sarah Bertoli, Thomas Prebet, Christian Recher, Norbert Vey, Induction Therapy For AML Patients With Daunorubicin Dose Of 60 Mg/m² and 90 Mg/m² Results In Similar Complete Response Rate, Relapse-Free and Overall Survival Blood. ,vol. 122, pp. 66- 66 ,(2013) , 10.1182/BLOOD.V122.21.66.66

Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, Brenda J. Chyla, Todd Busman, Evelyn McKeegan, Ahmed Salem, Ming Zhu, Justin L. Ricker, William Blum, Courtney D. DiNardo, Martin Dunbar, Rachel Kirby, Nancy Falotico, Joel D. Leverson, Rod A. Humerickhouse, Mack Mabry, Richard M. Stone, Hagop M. Kantarjian, Anthony G. Letai, A Phase 2 Study of ABT-199 (GDC-0199) in Patients with Acute Myelogenous Leukemia (AML) Blood. ,vol. 124, pp. 118- 118 ,(2014) , 10.1182/BLOOD.V124.21.118.118

Jorge E. Cortes, Martin S Tallman, Gary Schiller, Denise Trone, Guy Gammon, Stuart Goldberg, Alexander E Perl, Jean-Pierre Marie, Giovanni Martinelli, Mark Levis, Results Of a Phase 2 Randomized, Open-Label, Study Of Lower Doses Of Quizartinib (AC220; ASP2689) In Subjects With FLT3-ITD Positive Relapsed Or Refractory Acute Myeloid Leukemia (AML) Blood. ,vol. 122, pp. 494- 494 ,(2013) , 10.1182/BLOOD.V122.21.494.494

Cancer Genome Atlas Research Network, None, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia The New England Journal of Medicine. ,vol. 368, pp. 2059- 2074 ,(2013) , 10.1056/NEJMOA1301689

JK Weick, KJ Kopecky, FR Appelbaum, DR Head, LL Kingsbury, SP Balcerzak, JN Bickers, HE Hynes, JL Welborn, SR Simon, M Grever, A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood. ,vol. 88, pp. 2841- 2851 ,(1996) , 10.1182/BLOOD.V88.8.2841.BLOODJOURNAL8882841

Pierre Fenaux, Claude Chastang, Sylvie Chevret, Miguel Sanz, Hervé Dombret, Eric Archimbaud, Martin Fey, Consuelo Rayon, Françoise Huguet, Jean-Jacques Sotto, Claude Gardin, Pascale Cony Makhoul, Philippe Travade, Eric Solary, Nathalie Fegueux, Dominique Bordessoule, Jesus San Miguel, Harmut Link, Bernard Desablens, Aspasia Stamatoullas, E. Deconinck, Fréderic Maloisel, Sylvie Castaigne, Claude Preudhomme, Laurent Degos, A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia Blood. ,vol. 94, pp. 1192- 1200 ,(1999) , 10.1182/BLOOD.V94.4.1192

JF Bishop, JP Matthews, GA Young, J Szer, A Gillett, D Joshua, K Bradstock, A Enno, MM Wolf, R Fox, A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood. ,vol. 87, pp. 1710- 1717 ,(1996) , 10.1182/BLOOD.V87.5.1710.1710

Hagop Kantarjian, Susan O'Brien, Jorge Cortes, Francis Giles, Stefan Faderl, Elias Jabbour, Guillermo Garcia-Manero, William Wierda, Sherry Pierce, Jianqin Shan, Elihu Estey, Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. ,vol. 106, pp. 1090- 1098 ,(2006) , 10.1002/CNCR.21723